Pal SC - Search Results

1

The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review.

Ramírez-Mejía MM, Castillo-Castañeda SM, Pal SC, Qi X, Méndez-Sánchez N. Ramírez-Mejía MM, et al. Among authors: pal sc. J Clin Transl Hepatol. 2024 Nov 28;12(11):939-948. doi: 10.14218/JCTH.2024.00156. Epub 2024 Oct 21. J Clin Transl Hepatol. 2024. PMID: 39544246 Free PMC article. Review.

2

New terms for fatty liver disease other than MAFLD: Time for a reality check.

Méndez-Sánchez N, Pal SC. Méndez-Sánchez N, et al. Among authors: pal sc. J Hepatol. 2022 Dec;77(6):1716-1717. doi: 10.1016/j.jhep.2022.08.009. Epub 2022 Aug 18. J Hepatol. 2022. PMID: 35988685 No abstract available.

3

Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?

Mendez-Sanchez N, Pal SC. Mendez-Sanchez N, et al. Among authors: pal sc. Med Sci Monit. 2022 Jun 4;28:e937371. doi: 10.12659/MSM.937371. Med Sci Monit. 2022. PMID: 35707853 Free PMC article.

4

Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity.

Barranco-Fragoso B, Pal SC, Díaz-Orozco LE, Dorantes-Heredia R, Qi X, Méndez-Sánchez N. Barranco-Fragoso B, et al. Among authors: pal sc. Med Sci Monit. 2022 Aug 8;28:e937528. doi: 10.12659/MSM.937528. Med Sci Monit. 2022. PMID: 35934868 Free PMC article.

5

Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Ordóñez-Vázquez AL, Beltrán-Gall SM, Pal SC, Méndez-Sánchez N. Ordóñez-Vázquez AL, et al. Among authors: pal sc. Med Sci Monit. 2022 Sep 12;28:e938365. doi: 10.12659/MSM.938365. Med Sci Monit. 2022. PMID: 36093924 Free PMC article.

6

Interpretive bias on research evidence: Striving to meet the trustworthiness criteria.

Méndez-Sánchez N, Fassio E, Pal SC. Méndez-Sánchez N, et al. Among authors: pal sc. Ann Hepatol. 2023 Jan-Feb;28(1):100884. doi: 10.1016/j.aohep.2022.100884. Epub 2022 Nov 30. Ann Hepatol. 2023. PMID: 36460299 Free article. No abstract available.

7

Screening for MAFLD: who, when and how?

Pal SC, Méndez-Sánchez N. Pal SC, et al. Ther Adv Endocrinol Metab. 2023 Jan 21;14:20420188221145650. doi: 10.1177/20420188221145650. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 36699945 Free PMC article. Review.

8

How far are we from an approved drug for nonalcoholic steatohepatitis?

Méndez-Sánchez N, Pal SC, Córdova-Gallardo J. Méndez-Sánchez N, et al. Among authors: pal sc. Expert Opin Pharmacother. 2023 Jun;24(9):1021-1038. doi: 10.1080/14656566.2023.2206953. Epub 2023 May 1. Expert Opin Pharmacother. 2023. PMID: 37092896

9

Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis.

Pal SC, Méndez-Sánchez N. Pal SC, et al. World J Gastroenterol. 2023 Jul 7;29(25):3999-4008. doi: 10.3748/wjg.v29.i25.3999. World J Gastroenterol. 2023. PMID: 37476582 Free PMC article. Review.

10

Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study.

Pal SC, Castillo-Castañeda SM, Díaz-Orozco LE, Ramírez-Mejía MM, Dorantes-Heredia R, Alonso-Morales R, Eslam M, Lammert F, Méndez-Sánchez N. Pal SC, et al. Genes (Basel). 2023 Oct 13;14(10):1935. doi: 10.3390/genes14101935. Genes (Basel). 2023. PMID: 37895284 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters